berberine has been researched along with Colitis, Mucous in 10 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "We aimed to evaluate clinical symptoms in diarrhea predominant irritable bowel syndrome (IBS-D) receiving berberine hydrochloride in a randomized double-blind placebo-controlled clinical trial." | 9.20 | A Randomized Clinical Trial of Berberine Hydrochloride in Patients with Diarrhea-Predominant Irritable Bowel Syndrome. ( Chen, C; Fichna, J; Li, Q; Liu, Z; Lu, M; Pan, Q; Song, Z; Tao, C; Zheng, L, 2015) |
| " The hepatic inflammation, serum biochemical parameters and metabolome, fecal microbiota profile, fecal short-chain fatty acids (SCFAs), and correlations among them before and after berberine intervention were assessed." | 7.91 | Fecal Microbiota of Diarrhea-Predominant Irritable Bowel Syndrome Patients Causes Hepatic Inflammation of Germ-Free Rats and Berberine Reverses It Partially. ( Duan, L; Jia, Q; Pei, F; Sun, Q; Zhang, J; Zhang, L; Zhu, S, 2019) |
| "In mouse models, berberine prolonged GI transit and time to diarrhea in a dose-dependent manner, and significantly reduced visceral pain." | 7.81 | Berberine Improves Intestinal Motility and Visceral Pain in the Mouse Models Mimicking Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) Symptoms in an Opioid-Receptor Dependent Manner. ( Chen, C; Fichna, J; Kreis, M; Li, K; Li, Y; Liu, Z; Lu, M; Pan, Q; Song, A; Song, Z; Wang, K; Yu, Z; Zheng, L, 2015) |
| " Plasma samples were collected at 15 different points in time and the pharmacokinetic parameters were analyzed by WinNonlin software." | 5.42 | Pharmacokinetic difference of berberine between normal and chronic visceral hypersensitivity irritable bowel syndrome rats and its mechanism. ( Chen, Y; Dong, Y; Gong, Z; Guo, Y; Li, Y; Liu, X; Wang, Y; Weng, X; Yang, Q; Zhang, R; Zhou, B; Zhu, X, 2015) |
| " Plasma samples were collected at 15 different points in time and the pharmacokinetic parameters were analyzed by WinNonlin software." | 5.40 | Pharmacokinetic comparison of berberine in rat plasma after oral administration of berberine hydrochloride in normal and post inflammation irritable bowel syndrome rats. ( Chen, Y; Dong, Y; Gao, S; Gong, Z; Guo, Y; Wang, Y; Weng, X; Yang, Q; Zhang, H; Zhang, R; Zhu, X, 2014) |
| "We aimed to evaluate clinical symptoms in diarrhea predominant irritable bowel syndrome (IBS-D) receiving berberine hydrochloride in a randomized double-blind placebo-controlled clinical trial." | 5.20 | A Randomized Clinical Trial of Berberine Hydrochloride in Patients with Diarrhea-Predominant Irritable Bowel Syndrome. ( Chen, C; Fichna, J; Li, Q; Liu, Z; Lu, M; Pan, Q; Song, Z; Tao, C; Zheng, L, 2015) |
| "Berberine (BR) shows promise as a candidate for treating irritable bowel syndrome with diarrhea (IBS-D)." | 4.31 | Cannabidiol-Decorated Berberine-Loaded Microemulsions Improve IBS-D Therapy Through Ketogenic Diet-Induced Cannabidiol Receptors Overexpression. ( Fan, X; Liu, Y; Lu, M; Qu, D; Shi, J; Zhang, M, 2023) |
| " The hepatic inflammation, serum biochemical parameters and metabolome, fecal microbiota profile, fecal short-chain fatty acids (SCFAs), and correlations among them before and after berberine intervention were assessed." | 3.91 | Fecal Microbiota of Diarrhea-Predominant Irritable Bowel Syndrome Patients Causes Hepatic Inflammation of Germ-Free Rats and Berberine Reverses It Partially. ( Duan, L; Jia, Q; Pei, F; Sun, Q; Zhang, J; Zhang, L; Zhu, S, 2019) |
| "To investigate effects of berberine exerts on A20 expression and regulation of intestinal epithelial tight junctions via the TNF-α-NF-κB-MLCK pathway in Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)." | 3.91 | Berberine improves intestinal epithelial tight junctions by upregulating A20 expression in IBS-D mice. ( Chen, X; Guo, Y; Han, Q; Hou, Q; Huang, Y; Li, P; Liu, F; Wen, Y; Zhang, C; Zhu, S, 2019) |
| "In mouse models, berberine prolonged GI transit and time to diarrhea in a dose-dependent manner, and significantly reduced visceral pain." | 3.81 | Berberine Improves Intestinal Motility and Visceral Pain in the Mouse Models Mimicking Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) Symptoms in an Opioid-Receptor Dependent Manner. ( Chen, C; Fichna, J; Kreis, M; Li, K; Li, Y; Liu, Z; Lu, M; Pan, Q; Song, A; Song, Z; Wang, K; Yu, Z; Zheng, L, 2015) |
| "Berberine (BBR) has been used to treat patients with IBS, but the underlying therapeutic mechanism is little understood." | 1.51 | Berberine prevents stress-induced gut inflammation and visceral hypersensitivity and reduces intestinal motility in rats. ( Cen, YX; Guo, LL; Li, DF; Li, YX; Liu, TT; Luo, MH; Wang, JY; Wang, LS; Wei, C; Wu, BH; Xiong, F; Yao, J; Yu, ZC, 2019) |
| " Plasma samples were collected at 15 different points in time and the pharmacokinetic parameters were analyzed by WinNonlin software." | 1.42 | Pharmacokinetic difference of berberine between normal and chronic visceral hypersensitivity irritable bowel syndrome rats and its mechanism. ( Chen, Y; Dong, Y; Gong, Z; Guo, Y; Li, Y; Liu, X; Wang, Y; Weng, X; Yang, Q; Zhang, R; Zhou, B; Zhu, X, 2015) |
| " Plasma samples were collected at 15 different points in time and the pharmacokinetic parameters were analyzed by WinNonlin software." | 1.40 | Pharmacokinetic comparison of berberine in rat plasma after oral administration of berberine hydrochloride in normal and post inflammation irritable bowel syndrome rats. ( Chen, Y; Dong, Y; Gao, S; Gong, Z; Guo, Y; Wang, Y; Weng, X; Yang, Q; Zhang, H; Zhang, R; Zhu, X, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 8 (80.00) | 24.3611 |
| 2020's | 2 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fan, X | 1 |
| Shi, J | 1 |
| Liu, Y | 1 |
| Zhang, M | 1 |
| Lu, M | 3 |
| Qu, D | 1 |
| Yu, ZC | 1 |
| Cen, YX | 1 |
| Wu, BH | 1 |
| Wei, C | 1 |
| Xiong, F | 1 |
| Li, DF | 1 |
| Liu, TT | 1 |
| Luo, MH | 1 |
| Guo, LL | 1 |
| Li, YX | 1 |
| Wang, LS | 1 |
| Wang, JY | 1 |
| Yao, J | 1 |
| Zhang, JD | 1 |
| Liu, J | 1 |
| Zhu, SW | 1 |
| Fang, Y | 1 |
| Wang, B | 1 |
| Jia, Q | 2 |
| Hao, HF | 1 |
| Kao, JY | 1 |
| He, QH | 1 |
| Song, LJ | 1 |
| Liu, F | 2 |
| Zhu, BL | 1 |
| Owyang, C | 1 |
| Duan, LP | 1 |
| Zhang, L | 1 |
| Zhang, J | 1 |
| Pei, F | 1 |
| Zhu, S | 2 |
| Sun, Q | 1 |
| Duan, L | 1 |
| Hou, Q | 1 |
| Zhang, C | 1 |
| Huang, Y | 1 |
| Guo, Y | 3 |
| Li, P | 1 |
| Chen, X | 1 |
| Wen, Y | 1 |
| Han, Q | 1 |
| Chen, DP | 1 |
| Xiong, YJ | 1 |
| Lv, BC | 1 |
| Liu, FF | 1 |
| Wang, L | 1 |
| Tang, ZY | 1 |
| Lin, Y | 1 |
| Gong, Z | 2 |
| Chen, Y | 2 |
| Zhang, R | 2 |
| Wang, Y | 2 |
| Yang, Q | 2 |
| Zhang, H | 1 |
| Dong, Y | 2 |
| Weng, X | 2 |
| Gao, S | 1 |
| Zhu, X | 2 |
| Zhou, B | 1 |
| Liu, X | 1 |
| Li, Y | 2 |
| Chen, C | 2 |
| Tao, C | 1 |
| Liu, Z | 2 |
| Pan, Q | 2 |
| Zheng, L | 2 |
| Li, Q | 1 |
| Song, Z | 2 |
| Fichna, J | 2 |
| Wang, K | 1 |
| Yu, Z | 1 |
| Li, K | 1 |
| Song, A | 1 |
| Kreis, M | 1 |
1 trial available for berberine and Colitis, Mucous
| Article | Year |
|---|---|
A Randomized Clinical Trial of Berberine Hydrochloride in Patients with Diarrhea-Predominant Irritable Bowel Syndrome.
Topics: Abdominal Pain; Adult; Berberine; Diarrhea; Double-Blind Method; Female; Humans; Irritable Bowel Syn | 2015 |
9 other studies available for berberine and Colitis, Mucous
| Article | Year |
|---|---|
Cannabidiol-Decorated Berberine-Loaded Microemulsions Improve IBS-D Therapy Through Ketogenic Diet-Induced Cannabidiol Receptors Overexpression.
Topics: Animals; Berberine; Brain-Derived Neurotrophic Factor; Cannabidiol; Diarrhea; Diet, Ketogenic; Irrit | 2023 |
Berberine prevents stress-induced gut inflammation and visceral hypersensitivity and reduces intestinal motility in rats.
Topics: Animals; Berberine; Cytokines; Disease Models, Animal; Enteric Nervous System; Gastrointestinal Moti | 2019 |
Berberine alleviates visceral hypersensitivity in rats by altering gut microbiome and suppressing spinal microglial activation.
Topics: Animals; Berberine; Brain-Gut Axis; Cell Line; Fecal Microbiota Transplantation; Gastrointestinal Mi | 2021 |
Fecal Microbiota of Diarrhea-Predominant Irritable Bowel Syndrome Patients Causes Hepatic Inflammation of Germ-Free Rats and Berberine Reverses It Partially.
Topics: Animals; Berberine; Bifidobacterium; Diarrhea; Disease Models, Animal; Faecalibacterium; Fecal Micro | 2019 |
Berberine improves intestinal epithelial tight junctions by upregulating A20 expression in IBS-D mice.
Topics: Animals; Berberine; Diarrhea; Disease Models, Animal; Intestinal Absorption; Intestinal Mucosa; Irri | 2019 |
Effects of berberine on rat jejunal motility.
Topics: Adrenergic Agents; Animals; Arginine; Atropine; Berberine; Berberis; Calcium; Cholinergic Agents; En | 2013 |
Pharmacokinetic comparison of berberine in rat plasma after oral administration of berberine hydrochloride in normal and post inflammation irritable bowel syndrome rats.
Topics: Administration, Oral; Animals; Berberine; Cell Count; Chromatography, High Pressure Liquid; Disease | 2014 |
Pharmacokinetic difference of berberine between normal and chronic visceral hypersensitivity irritable bowel syndrome rats and its mechanism.
Topics: Animals; Area Under Curve; Berberine; Chromatography, High Pressure Liquid; Disease Models, Animal; | 2015 |
Berberine Improves Intestinal Motility and Visceral Pain in the Mouse Models Mimicking Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) Symptoms in an Opioid-Receptor Dependent Manner.
Topics: Animals; Berberine; Diarrhea; Disease Models, Animal; Female; Gastrointestinal Motility; Irritable B | 2015 |